Uncategorized

AI Assisted Neoantigen Identification: A Promising Approach for Personalized Cancer Immunotherapy

Cancer is a complex and heterogeneous disease that poses a major challenge for effective treatment. One of the most promising strategies to harness the power of the immune system to fight cancer is to target neoantigens, which are novel peptides generated by somatic mutations in tumor cells. Neoantigens can elicit specific and potent immune responses …

AI Assisted Neoantigen Identification: A Promising Approach for Personalized Cancer Immunotherapy Read More »

CAR-T vs TCR-T

CAR-T and TCR-T are two types of T-cell therapies used in cancer treatment. The key difference between the two is the type of modification made on the receptors to recognize a foreign cell. CAR-T cells identify surface antigens and initiate the immune response, while TCR-T cells identify MHC bound cells to initiate the immune response. …

CAR-T vs TCR-T Read More »